Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

UFS gets more than R3 Million for HIV/Aids activities
2007-12-13

 

In the picture are some of the members of the project team. From the left are: Mr Pieter du Plessis (Finances), Ms Estelle Heideman (HIV/Aids Co-ordinator: Lengau Agri Development Centre) and Rev Jaftha.
 

UFS gets more than R3 Million for HIV/Aids activities

The Chief Directorate: Community Service at the University of the Free State (UFS) has received more than R3 million to intensify activities regarding HIV/AIDS at all UFS campuses for the next seventeen months.

Higher Education HIV/AIDS Programme (HEAIDS) contributed R3 127 207 and the UFS R615 116 towards this initiative. The money will be used to implement intervention strategies from 1 January 2008 to 31 May 2009.

“The mandate poses an extensive challenge and puts pressure on the institution, but at the same time creates some incredible opportunities for intervention,” said the Chief Director of Community Service and Project Co-ordinator, Rev. Kiepie Jaftha.

HEAIDS is a nationally co-ordinated initiative to develop and strengthen the capacity of South African higher education institutions to respond to the causes, challenges and consequences of the HIV/AIDS pandemic in the sector. It is an initiative of the Department of Education and the implementing agency is Higher Education South Africa (HESA), an organisation representing vice-chancellors of tertiary institutions in South Africa.

The proposed areas and actions of intervention are categorised into three main components, namely:

- Prevention, treatment, care and support aimed at both students and staff on all UFS campuses.
Incorporation of HIV/AIDS issues into the teaching offerings of the UFS and the development of a formal policy in this regard.

- Implementation of an integrated management information system to empower stakeholders to make decisions and adapt actions by visualising facts, actions and progress on the overall HIV/AIDS programme.

The UFS met all the requirements of HEAIDS to qualify for this funding. A five-member team was formed to come up with a document entitled The Quest for an AIDS Competent Society that met the required standards.

“Each institution of higher learning had to identify and establish a project team, appoint a project leader, assign responsibilities to members of the team with different expertise, analyse the needs of the institution, and define and agree on projects in order to access the grant,” said Rev. Jaftha.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za  
13 December 2007

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept